Suchergebnisse - "Kazandjian, Dickran"

PubPharm (95)

81

Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease : influence of biopsy site and anticoagulation method

enthalten in: Leukemia & lymphoma | 2015

von Manasanch, E. | Salem, D. | Yuan, C. | +15

82

Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer : US Food and Drug Administration trial-level and patient-level analyses

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Blumenthal, G. | Karuri, S. | Zhang, H. | +7

83

Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method

enthalten in: Leukemia & lymphoma | 2015

von Manasanch, E. | Salem, D. | Yuan, C. | +15

84

Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses

enthalten in: Journal of clinical oncology / Englische Ausgabe | 2015

von Blumenthal, G. | Karuri, S. | Zhang, H. | +7

85

FDA approval summary : crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements

enthalten in: The oncologist | 2014

von Kazandjian, D. | Blumenthal, G. | Chen, H. | +5

86

Smoldering multiple myeloma : pathophysiologic insights, novel diagnostics, clinical risk models, and treatment strategies

enthalten in: Clinical advances in hematology & oncology : H&O | 2014

von Kazandjian, D. | Mailankody, S. | Korde, N. | +1

87

Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer

enthalten in: Cancer research | 2014

von Mathé, E. | Patterson, A. | Haznadar, M. | +11

88

Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer

enthalten in: Cancer research | 2014

von Math, E. | Patterson, A. | Haznadar, M. | +11

89

Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma

enthalten in: Cancer research | 2013

von Akagi, I. | Okayama, H. | Schetter, A. | +16

90

Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma

enthalten in: Cancer research | 2013

von Akagi, I. | Okayama, H. | Schetter, A. | +16